Reflexion Medical, partially based on research at UChicago, secured the Rise Fund as lead investor, with Pfizer and Johnson & Johnson returning.

US-based medical equipment manufacturer Reflexion Medical secured $100m in a series C round yesterday that featured the respective corporate venturing units of pharmaceutical firms Pfizer and Johnson & Johnson.

Pfizer Venture Investments and Johnson & Johnson Innovation – JJDC invested alongside the Rise Fund, an impact investment fund managed by TPG Growth, which led the round.

T. Rowe Price, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group and Venrock also participated in the series C round.

Reflexion Medical is working…